Previous Close | 7.15 |
Open | 5.87 |
Bid | 5.70 |
Ask | 5.80 |
Strike | 45.00 |
Expire Date | 2023-02-17 |
Day's Range | 5.87 - 5.87 |
Contract Range | N/A |
Volume | |
Open Interest | 526 |
Deciphera (DCPH) reports a wider-than-expected loss per share for the fourth quarter of 2022, while revenues driven by Qinlock sales, beat estimates.
The pharma giant’s UK chief is adding the company’s voice to scientists’ warnings of the dangers of antibacterial resistance
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.